DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.
Asia Pacific blood purification equipment market will grow by 6.3% annually with a total addressable market cap of $72.37 billion over 2022-2031 owing to the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Hemodialysis Device
- Blood Filtration Device
- CRRT Device
- Hemoperfusion Device
- Plasma Exchange Device
- Other Products
Based on Portability, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Portable Equipment
- Stationary Equipment
Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Renal Diseases
- Sepsis
- Other Indications
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Hospitals and Clinics
- Dialysis Centers
- Other End Users
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Asia Pacific Market by Product
3.1 Market Overview by Product
3.2 Hemodialysis Device
3.3 Blood Filtration Device
3.4 CRRT Device
3.5 Hemoperfusion Device
3.6 Plasma Exchange Device
3.7 Other Products
4 Segmentation of Asia Pacific Market by Portability
4.1 Market Overview by Portability
4.2 Portable Equipment
4.3 Stationary Equipment
5 Segmentation of Asia Pacific Market by Indication
5.1 Market Overview by Indication
5.2 Renal Diseases
5.3 Sepsis
5.4 Other Indications
6 Segmentation of Asia Pacific Market by End User
6.1 Market Overview by End User
6.2 Hospitals and Clinics
6.3 Dialysis Centers
6.4 Other End Users
7 Asia-Pacific Market 2021-2031 by Country
7.1 Overview of Asia-Pacific Market
7.2 Japan
7.3 China
7.4 Australia
7.5 India
7.6 South Korea
7.7 Rest of APAC Region
Companies Mentioned
- Aethlon Medical, Inc.
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerus Corporation
- CytoSorbents Corporation
- Fresenius SE and Co. KGaA
- Healthwell Medical Tech. Co., Ltd.
- Infomed SA
- Jafron Biomedical Co., Ltd.
- Kaneka Corporation
- Nikkiso Co., Ltd.
- Spectral Medical Inc.
- SWS Medical Group
For more information about this report visit https://www.researchandmarkets.com/r/m4cixx
The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
